Hypoxia Inducible Factor Signaling and Experimental Persistent Pulmonary Hypertension of the Newborn

Frontiers in Pharmacology- Switzerland

doi 10.3389/fphar.2015.00047

Full Text

Abstract

Available in

Categories

Date

March 11, 2015

Authors

Stephen Wedgwood

Satyan Lakshminrusimha

Paul T. Schumacker

Robin H. Steinhorn

Publisher

Frontiers Media SA

Related search

Persistent Pulmonary Hypertension of the Newborn: Pathophysiology and Treatment

Advances in Pulmonary Hypertension

English

Influence of 2‐Methoxyestradiol and Sex on Hypoxia‐Induced Pulmonary Hypertension and Hypoxia‐Inducible Factor‐1‐α

Journal of the American Heart Association

Cardiovascular Medicine

English

Patient Characteristics in Persistent Pulmonary Hypertension of the Newborn

Pulmonary Medicine

Respiratory Medicine

English

Clinical Syndromes and Associations With Persistent Pulmonary Hypertension of the Newborn

English

The Management of Persistent Pulmonary Hypertension of the Newborn: A Review

SAJCH South African Journal of Child Health

English

Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn

Basic and Clinical Pharmacology and Toxicology

English

Suppression of the Expression of Hypoxia-Inducible Factor-1α by RNA Interference Alleviates Hypoxia-Induced Pulmonary Hypertension in Adult Rats

International Journal of Molecular Medicine

English

Treatment of Severe Persistent Pulmonary Hypertension of the Newborn With Magnesium Sulphate.

Archives of Disease in Childhood

English

Tracheal Bronchus With Persistent Pulmonary Hypertension of the Newborn: A Case Report

Neonatal Medicine

English